Report Detail
Global Hereditary Angioedema Market Insights, Forecast to 2025
- RnM3518446 |
- 12 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
The global Hereditary Angioedema market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hereditary Angioedema market based on company, product type, end user and key regions.
This report studies the global market size of Hereditary Angioedema in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hereditary Angioedema in these regions.
This research report categorizes the global Hereditary Angioedema market by top players/brands, region, type and end user. This report also studies the global Hereditary Angioedema market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Market size by Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market size by End User
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hereditary Angioedema market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hereditary Angioedema market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hereditary Angioedema companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hereditary Angioedema submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hereditary Angioedema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hereditary Angioedema market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hereditary Angioedema Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hereditary Angioedema Market Size Growth Rate by Product
- 1.4.2 C1 Esterase Inhibitor
- 1.4.3 Kallikrein Inhibitor
- 1.4.4 Selective Bradykinin B2 Receptor Antagonist
- 1.5 Market by End User
- 1.5.1 Global Hereditary Angioedema Market Size Growth Rate by End User
- 1.5.2 Retail Pharmacies
- 1.5.3 Hospital Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hereditary Angioedema Market Size
- 2.1.1 Global Hereditary Angioedema Revenue 2014-2025
- 2.1.2 Global Hereditary Angioedema Sales 2014-2025
- 2.2 Hereditary Angioedema Growth Rate by Regions
- 2.2.1 Global Hereditary Angioedema Sales by Regions
- 2.2.2 Global Hereditary Angioedema Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hereditary Angioedema Sales by Manufacturers
- 3.1.1 Hereditary Angioedema Sales by Manufacturers
- 3.1.2 Hereditary Angioedema Sales Market Share by Manufacturers
- 3.1.3 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI)
- 3.2 Hereditary Angioedema Revenue by Manufacturers
- 3.2.1 Hereditary Angioedema Revenue by Manufacturers (2014-2019)
- 3.2.2 Hereditary Angioedema Revenue Share by Manufacturers (2014-2019)
- 3.3 Hereditary Angioedema Price by Manufacturers
- 3.4 Hereditary Angioedema Manufacturing Base Distribution, Product Types
- 3.4.1 Hereditary Angioedema Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hereditary Angioedema Product Type
- 3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hereditary Angioedema Sales by Product
- 4.2 Global Hereditary Angioedema Revenue by Product
- 4.3 Hereditary Angioedema Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hereditary Angioedema Breakdown Data by End User
6 North America
- 6.1 North America Hereditary Angioedema by Countries
- 6.1.1 North America Hereditary Angioedema Sales by Countries
- 6.1.2 North America Hereditary Angioedema Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hereditary Angioedema by Product
- 6.3 North America Hereditary Angioedema by End User
7 Europe
- 7.1 Europe Hereditary Angioedema by Countries
- 7.1.1 Europe Hereditary Angioedema Sales by Countries
- 7.1.2 Europe Hereditary Angioedema Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hereditary Angioedema by Product
- 7.3 Europe Hereditary Angioedema by End User
8 Asia Pacific
- 8.1 Asia Pacific Hereditary Angioedema by Countries
- 8.1.1 Asia Pacific Hereditary Angioedema Sales by Countries
- 8.1.2 Asia Pacific Hereditary Angioedema Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hereditary Angioedema by Product
- 8.3 Asia Pacific Hereditary Angioedema by End User
9 Central & South America
- 9.1 Central & South America Hereditary Angioedema by Countries
- 9.1.1 Central & South America Hereditary Angioedema Sales by Countries
- 9.1.2 Central & South America Hereditary Angioedema Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hereditary Angioedema by Product
- 9.3 Central & South America Hereditary Angioedema by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hereditary Angioedema by Countries
- 10.1.1 Middle East and Africa Hereditary Angioedema Sales by Countries
- 10.1.2 Middle East and Africa Hereditary Angioedema Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hereditary Angioedema by Product
- 10.3 Middle East and Africa Hereditary Angioedema by End User
11 Company Profiles
- 11.1 Pharming Group NV
- 11.1.1 Pharming Group NV Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pharming Group NV Hereditary Angioedema Products Offered
- 11.1.5 Pharming Group NV Recent Development
- 11.2 Shire plc
- 11.2.1 Shire plc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Shire plc Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Shire plc Hereditary Angioedema Products Offered
- 11.2.5 Shire plc Recent Development
- 11.3 CSL Limited
- 11.3.1 CSL Limited Company Details
- 11.3.2 Company Business Overview
- 11.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 CSL Limited Hereditary Angioedema Products Offered
- 11.3.5 CSL Limited Recent Development
- 11.4 iBio Inc.
- 11.4.1 iBio Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 iBio Inc. Hereditary Angioedema Products Offered
- 11.4.5 iBio Inc. Recent Development
- 11.5 BioCryst Pharmaceuticals, Inc.
- 11.5.1 BioCryst Pharmaceuticals, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
- 11.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
- 11.6 Ionis Pharmaceuticals, Inc.
- 11.6.1 Ionis Pharmaceuticals, Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
- 11.6.5 Ionis Pharmaceuticals, Inc. Recent Development
12 Future Forecast
- 12.1 Hereditary Angioedema Market Forecast by Regions
- 12.1.1 Global Hereditary Angioedema Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hereditary Angioedema Revenue Forecast by Regions 2019-2025
- 12.2 Hereditary Angioedema Market Forecast by Product
- 12.2.1 Global Hereditary Angioedema Sales Forecast by Product 2019-2025
- 12.2.2 Global Hereditary Angioedema Revenue Forecast by Product 2019-2025
- 12.3 Hereditary Angioedema Market Forecast by End User
- 12.4 North America Hereditary Angioedema Forecast
- 12.5 Europe Hereditary Angioedema Forecast
- 12.6 Asia Pacific Hereditary Angioedema Forecast
- 12.7 Central & South America Hereditary Angioedema Forecast
- 12.8 Middle East and Africa Hereditary Angioedema Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hereditary Angioedema Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hereditary Angioedema . Industry analysis & Market Report on Hereditary Angioedema is a syndicated market report, published as Global Hereditary Angioedema Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hereditary Angioedema market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
